Managers / Q3 2021 · view latest →
Kent Lake Capital LLC
CIK 0001777141 · 1 E LIBERTY ST, STE 600 #1025, RENO, NV, 89501 · 4157992720
Summary
Kent Lake Capital LLC reported $233M in U.S.-listed holdings across 31 positions for Q3 2021.
Its largest position, SSTK, represents 11.2% of the portfolio.
Compared with Q2 2021, the fund opened 10 new positions and exited 7.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 83.8% · $195M
- Other · 14.2% · $33M
- ADR · 2.0% · $5M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TREMOR INTL LTD | NEW | +594.7K | 594.7K | +$11M | $11M |
| EHCENCOMPASS HEALTH CORP | NEW | +110.0K | 110.0K | +$8M | $8M |
| SMLRSEMLER SCIENTIFIC INC | NEW | +60.0K | 60.0K | +$8M | $8M |
| ONTFON24 INC | NEW | +229.4K | 229.4K | +$5M | $5M |
| AVAHAVEANNA HEALTHCARE HLDGS INC | NEW | +443.1K | 443.1K | +$4M | $4M |
| SUPNSUPERNUS PHARMACEUTICALS INC | NEW | +100.0K | 100.0K | +$3M | $3M |
| AMEDAMEDISYS INC | NEW | +12.8K | 12.8K | +$2M | $2M |
| APRIA INC | NEW | +40.5K | 40.5K | +$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2024 | $222M | 44 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $229M | 43 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $259M | 47 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $260M | 52 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $218M | 50 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $148M | 35 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $167M | 38 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $153M | 37 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $182M | 47 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $161M | 39 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $193M | 37 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $233M | 31 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $261M | 28 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021REVEALED | $246M | 30 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $211M | 32 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.